CINCINNATI, Feb. 29 Kendle (Nasdaq: KNDL), aleading, global full-service clinical research organization, today announcedthat Vice President and Chief Marketing Officer Simon Higginbotham willparticipate in the 29th Annual Raymond James Institutional InvestorsConference. The conference will be held at the Hyatt Regency Grand Cypress inOrlando, March 2-5, 2008. Kendle's presentation is scheduled for Wednesday,March 5 at 1:40 p.m. Eastern Time.
(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO )
The public is invited to listen to a live webcast of Kendle's presentationat http://www.kendle.com (click on the link provided in the Investor Eventssection) or at http://www.wsw.com/webcast/rj33/kndl/. An archived version canbe accessed following Kendle's presentation and will be available throughApril 4. Slides accompanying the presentation will be available by 9 a.m.Eastern Time on March 5 at http://www.kendle.com in the Investor Relationssection.
Kendle International Inc. (Nasdaq: KNDL) is among the world's leadingglobal clinical research organizations. We deliver innovative and robustclinical development solutions -- from first-in-human studies through marketlaunch and surveillance -- to help the world's biopharmaceutical companiesmaximize product life cycles and grow market share.
Our global clinical development business is focused on five regions --North America, Europe, Asia/Pacific, Latin America and Africa -- to meetcustomer needs. We have conducted clinical trials and provided regulatory andpharmacovigilance services in more than 80 countries. Kendle was named "TopCRO to Work With" in the Thomson CenterWatch 2007 survey of U.S. investigativesites and "Best CRO" for 2007 and 2006 by leading global pharmaceuticalpublication Scrip.
Additional information and investor kits are available upon request fromKendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from theCompany's Web site at http://www.kendle.com.
SOURCE Kendle International Inc.